Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

China flag China · Delayed Price · Currency is CNY
73.00
+1.32 (1.84%)
Apr 28, 2026, 3:00 PM CST
Market Cap15.48B +77.6%
Revenue (ttm)2.88B +26.7%
Net Income239.81M +19.0%
EPS1.13 +17.7%
Shares Out212.10M
PE Ratio64.60
Forward PE37.44
Dividend0.23 (0.32%)
Ex-Dividend Daten/a
Volume4,222,974
Average Volume4,152,200
Open72.24
Previous Close71.68
Day's Range71.68 - 74.87
52-Week Range36.50 - 90.58
Beta0.65
RSI51.24
Earnings DateApr 23, 2026

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China. [Read more]

Sector Healthcare
Founded 2006
Employees 3,826
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688131
Full Company Profile

Financial Performance

In 2025, SHA:688131's revenue was 2.88 billion, an increase of 26.73% compared to the previous year's 2.27 billion. Earnings were 239.81 million, an increase of 18.96%.

Financial Statements